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The main aim of this study was to find and describe province-specific estimates 
of incidence in females by age groups for esophagus cancer. The data used in this 
study were collected in a cancer registry that was conducted by Health Deputy 
of Golestan province for a period of 1 year (2004). The age distribution was 
collected according to the following age strata: 0-4, 5-9, 10-14, 15-19, 20-24, 25-29, 
30-34, 35-39, 40-44, 45-49, 50-54, 55-59, 60-64, 65-69, 70-74, 75-79, 80-84 and85 
above. Esophagus cancer data was identified and collected through the 18 
Pathology Laboratory centers (where female populations referred to these 
centers) in Golestan province. A total of 348 primary cancer cases were captured. 
From these 32 cases was esophagus cancer. There were 26 squamous cell 
carcinoma (81.25%), 1 adenocarcinoma (3.12%). Esophagus cancer incidence 
among females in Golestan province was 7 .62/100000. But esophagus cancer with 
the highest ASR: 127 .91/100,000 was in age 75-79. The incidence of esophagus 
cancer in age over 75-79 has risen sharply and it was the lowest in age 30-34 
(ASR: 1.68/100,000). For the present time it can be said that esophagus cancer in 
females appear to be one of the most prevalent and serious type of cancer 
(especially squamous cell carcinoma) in Golestan province and esophagus cancer 
is rising with ageing. 
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INTRODUCTION 
Cancer is becoming a leading cause of death in many 
cormtries of the world. In 1984, over half of the annual 
world total of 5.8 million new cancer cases was reported 
from developing countries (Parkin et al., 2005). Many 
studies demonstrate that cancer incidence among different 
people are heterogeneous. Esophageal cancer is the sixth 
most common cause of cancer mortality worldwide. The 
incidence of this disease shows a striking geographic 
variation in the world; a 20 fold variation is observed 
between high-risk China and low-risk western Africa 
(Parkin et al., 2005). Geographic variability is even more 
marked when smaller llllits are studied; for example, when 
comparisons are made among colll1tries or even within 
cormtries. It seems that the environmental carcinogens 
responsible show important geographic differences 
(Munoz and Day, 1996). In Europe and North America, 
90% of esophageal cancer is caused by tobacco plus 
alcohol. In the high risk colll1tries of South America, 
hot beverages, particularly hot mate are important 
(Parkin et al., 1999). Esophageal cancer is one of the most 
common malignant tumors with a high incidence in such 
regions as China, Iran, South Africa, Uruguay, France and 
Italy (Lu et al., 1999). Some of the highest rates occur in 
northern China and Northern Iran, where incidence 
exceeds 100 in 100,000 individuals; in the US., the 
incidence is less than 5 per 100,000, although rates are 
nearly quadruple for African Americans (Fisher and 
Brady, 1998). Annually, it is estimated that 15,560 
Americans will be diagnosed with esophageal cancer and 
13,940 will die of this malignancy. Of the new cases, it is 
estimated that 12, 130 will occur inmen and 3,430 will occur 
in women (American Cancer Society, 2007). Iran is one of 
the knovvn areas with a high incidence of esophageal 
cancer. Most of the patients in Iran have been reported 
from the North and Northeast regions of the cormtry. In 
one survey by the Iran Cancer Institute, 9% of all cancers 
and 27% of gastrointestinal cancers were esophageal 
carcinoma. The male to female ratio was 1. 7/1 
(Ghavarnz.adeh et al., 2001). A recent report from Ministry 
of Health shows that more than 70% of deaths are caused 
by cardiovascular diseases, injuries and cancers, while 
fewer than 3% of deaths are the consequence of 
infectious or parasitic diseases. Therefore rmderstanding 
and quantifying the burden of cancer as one of the three 
major causes of death in the cormtry is essential 
(Naghavi, 2000). Study of cancer cases in this region 
during the 1996-2000 period showed that Age­
Standardized Rates (ASR) for esophageal cancer in 
females was 36.3/100000 (Sernnani et al., 2006). In 2002 and 
2003 two separate reports of population based cancer 
registries were published from Iran. These reports showed 
that Age-Standardized Rates (ASR) for esophageal cancer 
in females was 14.41100000 (Sadjadi et al., 2002). The 
main arm of this study was to find and describe 
province-specific estimates of incidence by age groups 
for esophagus cancer in the year 2004. 
MATERIALS AND METHODS 
The data used in this study were collected in a cancer 
registry that was conducted by Health Deputy of 
Golestan province in Iran for a period of 1 year (2004). 
This study focuses on female cancer registry. Golestan 
province is located in North of Iran (South East of 
Caspian Sea). The collected data included population 
distribution by gender (female) and age, divided into five­
year intervals. The age distribution was collected 
according to the following age strata: 0-4, 5-9, 10-14, 15-19, 
20-24, 25-29, 30-34, 35-39, 40-44, 45-49, 50-54, 55-59, 60-64, 
65-69, 70-74, 75-79, 80-84 and 85 above. Different cancer 
data was identified and collected through the 18 
Pathology Laboratory centers (where male populations 
referred to these centers) and using a structured 
questionnaire, trained personnel conducted in-person 
interviews to collect information on esophagus cancer in 
the Golestan province. The newly diagnosed cases 
detected by histopathological, cytological examinations. 
These were then sent to the Cancer Registry Office of the 
province and to the registry mrit in the Health Deputy. 
Age-specific rates, annual age-adjusted rates (ASRs) per 
100,000 person years were calculated using the direct 
methods of standardization to the world population. The 
data were summarized in a data sheet and coded using the 
ICD-0. The data were recorded at different levels due to 
a need for correct registration. This has been done by 
iarccrgtools-203 software. 
RESULTS 
A total of 348 cases with cancer from all sites were 
captured during the one year period, 2004. From these 
32 (9.20%) was females esophagus cancer. There were 
26 squamous cell carcinoma (81.25%), 1 adenocarcinoma 
(3.12%). The incidence for squamous cell carcinoma was 
the highest in Golestan province. The results from 
Golestan province Cancer Registry for the year period 
2004 show that cancer of esophagus is the second 
common cancer of women. The Annual Specific Rate 
(ASR) is 7.62 per 100,000 in females. The highest 
esophagus cancer incidence among females in Golestan 
province was in age 75-79 (ASR: 127.91/100,000). The 
esophagus cancer incidence according to age specific 
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Table 1: Esophagus cancer incidence among females in Golestan province in 2004 
Ages (year) 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 85+ 
Persons 69465 84583 112921 123107 89519 67719 59689 52192 35723 29885 28116 21321 13615 8240 8614 3909 2923 1818 
Incidence 1.68 1.92 2.80 3.35 17.78 14.07 36.72 46.54 46.44 127.91 34.21 55.01 
rates 
er 100000 
*: - No cancer incidence 
was as follow: inages0-4,5-9, 10-14, 15-19,20-24and 
25-29 no esophagus cancer incidence (ASR: 0.00/100,000), 
in age 30-34 (ASR: 1.68/100,000), in age 35-39 (ASR: 
1.92/100,000), in age 40-44 (ASR: 2.80/100,000), in age 
45-49 (ASR: 3.35/100,000), in age 50-54 (ASR: 
17.78/100,000), inage 55-59 (ASR: 14.07/100,000), in age 
60-64 (ASR:36.72/IOO,OOO), m age 65-69 (ASR: 
48.54/100,000), in age 70-74 (ASR: 46.44/100,000) in age 
75-79 (ASR: 127.91/100,000), in age 80-84 (ASR: 
34.21/100,000) and in age over 85 (ASR: 55.01/100,000). 
The incidence of esophagus cancer in age 7 5-79 has risen 
sharply and in age 30-34 it was the lowest The esophagus 
cancer incidence according to age specific is shoV\Tll in 
Table I. 
DISCUSSION 
Esophagus cancer is a relatively rare form of cancer, 
but some world areas have a markedly higher incidence 
than others: China, India and Japan, as well as the United 
Kingdom, appear to have a higher incidence, as well as 
the region arolllld the Caspian Sea. Annual incidence is 
between0.6-6per 100,000for females (Stewart et al., 2003). 
The findings of this study showed that esophagus cancer 
is one of the most common cancers in the Golestan 
province among females. The registry showed that the 
annual ASR for esophagus cancer was 7.62 per 100000 
populations among females (the second common cancer). 
Comparison of the ASR for esophagus cancer among 
females in Golestan province with those of esophagus 
cancer worldwide show that the Golestan province is 
lower -risk areas than other places. The incidence of 
esophagus cancer rises from age 30 years old (ASR: 
1.68/100,000) and is highest in age 75-79 years old. There 
are many factors for incidence of esophagus cancer. Diet 
certainly plays an important role. Risk is increased by high 
intakes of some traditionally preserved salted foods, 
especially salted fishes and cucwnber. Risk is probably 
increased with the use of pesticide in agricultural 
products in this area such as some cucwnber, tomatoes, 
strawberry and etc., using deposed wheat's and corns 
contaminated with aflatoxin, hot tea drink habiting, 
change in lifestyle, the high caloric and fatty diet intake. 
Risk is decreased by high intakes of fruits and vegetables 
which may be in part related to their vitamins A, C and E 
content (Cheng and Day, 1996). Excessive use of tobacco 
and alcohol has clearly been shoV\Tll to be a risk factor for 
esophagus cancer (Warwick and Harrington, 1973). In 
fact, it is estimated that 90% or more of the risk of 
esophageal cancer in Western Europe and North America 
can be attributed to tobacco and alcohol (Mlllloz and 
Day, 1996). The incidence of esophageal cancer in the 
Golestan province was lower when compared with other 
places in the world, which may be related to the relatively 
low conswnption of alcohol in the region. The increasing 
conswnption of cigarettes smoking has also been clearly 
accepted as increasing the risk of esophagus cancer 
(WCRF, 1997). However there are cases of esophageal 
cancer in people of this area who have never taken 
alcohol nor smoked cigarettes in their lifetime. This 
finding calls for further study, as there is a high 
prevalence of smoking in some cities of Golestan 
province, which maybe tends to increase esophageal 
cancer rates. Compared with the data of 1999-2000 
(Sernnani et al., 2006), 2002 and 2003 (Sadjadi et al., 2002) 
the incidence of esophageal cancer is much lower. This 
decrease can be attributed to better economic status and 
personal health, better nutrition and changing in high-risk 
behavior (Malekzadeh et al., 2004; Poursharns et al., 
2005). Clinicians should follow recommended screening 
guidelines and encourage their patients before age 30 and 
older (in this area). Clinicians should also ensure that 
patients at high risk for esophagus cancer are identified 
and offered appropriate referrals and treatment. Continued 
research is needed on the causes, prevention and 
treatment of esophagus cancer. In this area the incidence 
of esophagus cancer is started from age 30 years old 
onward. The age specific esophagus cancer among 
females maybe is the second cause of cancer deaths 
(after breast cancer) in Golestan province. For the present 
time it can be said that esophagus cancer (especially 
squamous cell carcinoma) in females appear to be one of 
the most prevalent and serious type of cancer after 
stomach cancer in Golestan province and is rising with 
agemg. Thoughtfully designed epidemiological and 
clinical studies are pivotal to unravel the details of why 
and how these are happening and help to plan what 
should be done to combat effectively with these still 
deadly diseases. Therefore, further studies to look for the 
etiology and possible risk factors seem logical. 
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